<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MG4NCM9" height="0" width="0" style="display:none;visibility:hidden" aria-hidden="true"></iframe>

Recommended

Discover how to understand pain pathways and accelerate the search for next-generation analgesics – register today

WEBINAR | Join top cancer researchers to explore advances transforming early discovery, from new targets and models to the therapies of tomorrow

NEW REPORT | Explore how data-driven systems improve reproducibility, speed decisions and make scale achievable across research and development.

The scientific advances driving cancer drug discovery – find out more

Meet the precision peptide changing how we study pain

List view / Grid view

News

Immunomic Therapeutics awarded $1.2m to develop peanut allergy treatment

13 May 2015 | By Victoria White

Immunomic Therapeutics has been awarded a US $1.2 million grant for the development of its ARA-LAMP-vax technology against peanut allergies...

Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease

13 May 2015 | By Victoria White

Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...

Genethon and Selecta Biosciences to research repeat dosing for gene therapies

13 May 2015 | By Victoria White

Genethon and Selecta Biosciences have announced an ongoing research collaboration with the goal of enabling repeat dosing for gene therapies...

Soligenix enters agreement with Emergent BioSolutions to develop ricin vaccine RiVax

13 May 2015 | By Victoria White

Soligenix has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for RiVax...

Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients

13 May 2015 | By Victoria White

A Phase I clinical trial of INVAC-1, an innovative therapeutic DNA vaccine, which specifically targets the telomerase enzyme (hTERT), has commenced...

New “map” of TTLL7 protein helps researchers understand cellular transport

12 May 2015 | By

Scientists from TSRI and NIH have mapped out the structure of an important protein involved in cellular function and nervous system development - TTLL7...

Significant progress made towards individualised cancer immunotherapy

12 May 2015 | By Victoria White

Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...

Haplogen and Cyclenium Pharma announce research and development collaboration

12 May 2015 | By Victoria White

Cyclenium Pharma and Haplogen have signed a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas...

BioNTech and Lilly enter into cancer immunotherapy research collaboration

12 May 2015 | By Victoria White

BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...

FDA grants QIDP and Fast Track Designations to CD101 IV for the treatment of candidemia

11 May 2015 | By Victoria White

Cidara Therapeutics has announced that the FDA has designated the Company’s lead antifungal product candidate, CD101 IV, as a QIDP with Fast Track status...

lycera

lycera

Studies confirm TRXE-009 kills resistant paediatric brain cancer cells

11 May 2015 | By Victoria White

Novogen, in conjunction with Australian paediatric cancer researchers, released key preclinical data on experimental cancer drug-candidate, TRXE-009...

GSK partners with UNC-Chapel Hill to accelerate search for HIV cure

11 May 2015 | By Victoria White

UNC-Chapel Hill and GSK have announced the creation of a dedicated HIV Cure centre and a new company that will focus on discovering a cure for HIV/AIDS...

Hemispherx Biopharma receives EMA Orphan Medicine Designation for Ampligen to treat Ebola

11 May 2015 | By Victoria White

Hemispherx Biopharma has received formal notification approving its Orphan Medicinal Product Application for Ampligen for the treatment of Ebola...

PhoreMost awarded £1.4M to develop lead oncology programme targeting mutant KRAS cancers

11 May 2015 | By Victoria White

PhoreMost has been selected to receive a funding award of £1.4M from Innovate UK to develop its lead oncology programme targeting mutant KRAS cancers...

Positive preclinical results support the development of ISTH0036 for the treatment of glaucoma

11 May 2015 | By Victoria White

Isarna Therapeutics presented preclinical data for its lead candidate ISTH0036 in one podium presentation and two poster publications at ARVO 2015...

Page 434 of 462
<
1
...
429
430
431
432
433
434
435
436
437
438
...
462
>

© Russell Publishing Limited, 2010-2025. All rights reserved. Terms & Conditions | Privacy Policy | Cookie Policy

Website development by e-Motive Media Limited.

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KM6ZDN2" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Cookie Settings

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as "Necessary" are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies "Advertising & Targeting", "Analytics" and "Performance", these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to 'Enabled' or 'Disabled', then click 'Save and Accept'. View our Cookie Policy page.

Necessary

Necessary

Always Enabled

Necessary cookies enable the core functionality of the website, including security, network management and accessibility. These cookies do not store any personal information. You may disable these by changing your browser settings, but this may affect how the website functions.

Cookie	Type	Duration	Description
cookielawinfo-checkbox-advertising-targeting	persistent	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	persistent	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	session	1 year	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	persistent	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	session	1 year	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Advertising & Targeting

Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.

Cookie	Type	Duration	Description
advanced_ads_browser_width	persistent	1 month	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	persistent	2 years	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	persistent	1 month	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	persistent	1 year	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	persistent	2 years	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	persistent	2 years	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	persistent	3 months	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	persistent	1 month	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	persistent	5 months	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Analytics

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

Cookie	Type	Duration	Description
bcookie	persistent	2 years	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	persistent	30 minutes	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	session	1 year	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	persistent	1 day	This cookie is set by LinkedIn and used for routing.
lissc	persistent	11 months	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	persistent	2 years	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	persistent	2 years	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	persistent	20 minutes	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	persistent	20 minutes	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	persistent	20 minutes	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	persistent	2 years	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	persistent	1 minute	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	persistent	1 day	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Performance

Performance cookies include cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

Cookie	Type	Duration	Description
cf_ob_info	persistent	1 minute	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	persistent	1 minute	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	session	1 year	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	persistent	1 month	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	persistent	Until cleared	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	session	1 year	This cookie is set by Youtube and is used to track the views of embedded videos.